The short answer
EKRA, the Eliminating Kickbacks in Recovery Act, makes it a federal crime to pay or receive kickbacks for referrals to recovery homes, treatment facilities, or clinical labs, and it applies to all payers, including private and cash-pay. The catch that surprises many treatment centers: paying a marketer per lead or per admission can be treated as an illegal kickback. That makes an owned-channel, flat-fee model, where you own your inquiries and pay for the system rather than per referral, a genuinely safer footing. This is general information, not legal advice.
Treatment centers spend heavily on marketing, and the way that spend is structured carries real legal risk that most other industries never think about. EKRA is the reason. If you pay for leads in this field, how you pay matters as much as how much. Here’s the plain-English version.
What it is
What is EKRA?
EKRA (18 U.S.C. 220) is a federal law passed in 2018 to fight patient brokering and kickback schemes in addiction treatment. It prohibits knowingly paying or receiving any remuneration in return for referring a patient to a recovery home, clinical treatment facility, or laboratory. Unlike some healthcare laws that only cover federal programs, EKRA applies to all payers, so private insurance and cash-pay arrangements are squarely in scope.
The penalties are serious: up to $200,000 in fines and up to 10 years in prison per offense.
The marketing trap
Why is paying per lead or per admission risky?
Here’s the part that catches marketers off guard. EKRA restricts compensation tied to the volume or value of referrals. So paying a lead vendor or marketer a fee per lead, per call, or per admission can look exactly like paying for referrals, which is what EKRA prohibits. Courts and enforcement have taken a hard line on percentage-of-revenue and per-patient marketing arrangements in this space.
The structural risk
A marketing deal that pays out based on how many patients it brings in is the exact pattern EKRA was written to stop. The safer structures separate marketing pay from referral volume entirely.
The safer model
How should treatment centers pay for marketing?
The common guidance is to structure marketing compensation so it isn’t tied to the number or value of patients referred. In practice, that points toward:
- Flat fees for services and systems, not per-lead or per-admission payments.
- Owning your own inquiries. When leads come into channels you own, from your own ads, forms, and follow-up, you’re not buying referrals from a broker.
- Paying for the tool, not the outcome-per-head. A flat-fee system that answers and follows up with your inquiries is a service you operate, not a referral you purchased.
This is where an owned-channel, done-for-you follow-up model has a real compliance advantage over pay-per-lead vendors. You keep your inquiries in-house and pay a predictable fee for the system that handles them, rather than a per-patient bounty. The speed and warmth of that response still matter enormously, as we cover in speed to lead for addiction treatment centers. Getting the response right and the payment structure right go hand in hand.
Own your inquiries, answer them fast
Fill out the form and watch your phone. See a flat-fee, owned-channel system respond in about 60 seconds, no per-lead or per-admission arrangement involved.
This article is general information, not legal advice. EKRA is complex and enforcement is evolving, so consult qualified healthcare counsel before structuring any marketing arrangement.
Frequently asked questions
What does EKRA prohibit?
Is paying per lead for treatment marketing illegal?
How can treatment centers market compliantly?
Does EKRA only apply to federal insurance?
Sources
- Eliminating Kickbacks in Recovery Act, 18 U.S.C. 220: uscode.house.gov
- Mintz / Chapman Law Group, EKRA and marketing compensation analysis: mintz.com; chapmanlawgroup.com
- Recent EKRA enforcement and per-patient marketing rulings (2024/2025 commentary): healthlawdiagnosis.com

